1. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy

Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy

R Lever, K Hadley, D Downey, R Mackie

Clinical Trial

49 participants

1988

26 citations

Key insights related to Mupirocin from this study:


  • What is this paper about?

    This paper studied whether mupirocin, a topical antibiotic, could help treat atopic dermatitis by reducing Staphylococcus aureus bacteria on the skin. The study looked at both the bacteria levels and clinical symptoms before and after treatment.

  • How did the authors study this?

    The researchers conducted a double-blind, placebo-controlled crossover study. They measured bacteria levels on patients' skin before treatment, after 2 weeks of either mupirocin or placebo treatment, and during a 4-week follow-up period.

  • What populations did the authors study?

    The study included 49 patients with atopic dermatitis (45 completed the study). Almost all patients had heavy colonization of Staphylococcus aureus on their skin, even without visible infection.

  • What conclusions can we draw?

    The authors concluded that mupirocin effectively reduces both Staphylococcus aureus colonization and clinical symptoms in atopic dermatitis. The treatment was safe with no serious side effects. Even though bacteria returned after treatment stopped, patients' symptoms didn't get worse during the study period.

Did this article interest you?

As a member of the Lemma Health community, you'll stay up to date with research, hear about new products, and get exclusive access to discounts.

By submitting your email, you acknowledge our Terms & Conditions and Privacy Policy

Group of men

Ready for better skin health?

At Lemma Health, we provide evidence-based skin care. Access providers in all 50 states. Receive your medications delivered.